Form 8-K - Current report:
SEC Accession No. 0000078003-25-000159
Filing Date
2025-11-13
Accepted
2025-11-13 15:33:11
Documents
13
Period of Report
2025-11-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K pfe-20251113.htm   iXBRL 8-K 35534
  Complete submission text file 0000078003-25-000159.txt   214793

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20251113.xsd EX-101.SCH 3420
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20251113_def.xml EX-101.DEF 17164
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20251113_lab.xml EX-101.LAB 31865
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20251113_pre.xml EX-101.PRE 18071
15 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20251113_htm.xml XML 7160
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 251477904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)